Needham Maintains Buy on DocGo, Lowers Price Target to $7
Portfolio Pulse from Benzinga Newsdesk
Needham analyst Ryan MacDonald has maintained a Buy rating on DocGo (NASDAQ:DCGO) but lowered the price target from $10 to $7.
May 09, 2024 | 5:26 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Needham analyst Ryan MacDonald reaffirmed a Buy rating on DocGo but reduced the price target from $10 to $7.
The reduction in price target by Needham, despite maintaining a Buy rating, could lead to short-term negative sentiment among investors, potentially impacting DocGo's stock price negatively.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100